recently revealed that they own a 14.7% stake in Female Health Company (The) (NASDAQ:FHCO) in a Schedule 13D/A disclosure that was filed with the SEC on Wednesday, August 2nd. The investor owns 7,826,991 shares of the stock valued at about $9,862,009. The reporting parties listed on the disclosure included Harry Fisch, MD and K&H Fisch Family Partners, LLC. The disclosure is available through the SEC website at this hyperlink.
provided the following explanation of their ownership:
Warning: file_get_contents(): php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/acctmp/public_html/download.php on line 6
): failed to open stream: php_network_getaddresses: getaddrinfo failed: Name or service not known in /home/acctmp/public_html/download.php on line 6
Female Health Company (FHCO) traded down 0.79% during mid-day trading on Friday, hitting $1.26. 53,038 shares of the stock were exchanged. The company’s market cap is $39.49 million. The company has a 50-day moving average price of $1.14 and a 200-day moving average price of $1.07. Female Health Company has a one year low of $0.72 and a one year high of $1.50.
Female Health Company (The) (NASDAQ:FHCO) last issued its quarterly earnings data on Tuesday, May 9th. The company reported ($0.06) earnings per share for the quarter. The firm had revenue of $2.41 million for the quarter. Female Health Company (The) had a negative return on equity of 12.51% and a negative net margin of 29.27%. On average, analysts predict that Female Health Company will post $0.15 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Female Health Company (The) (FHCO) Stake Owned by Fisch Harry” was published by Rincon Hill News and is the property of of Rincon Hill News. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://rinconhillneighbors.org/2017/08/12/female-health-company-the-fhco-stake-held-by-fisch-harry-updated.html.
Several analysts have issued reports on FHCO shares. Rodman & Renshaw started coverage on shares of Female Health Company (The) in a research report on Wednesday, July 26th. They issued a “buy” rating and a $5.00 price objective for the company. HC Wainwright set a $5.00 price objective on shares of Female Health Company (The) and gave the company a “buy” rating in a research report on Wednesday, July 26th. Finally, ValuEngine downgraded shares of Female Health Company (The) from a “hold” rating to a “sell” rating in a research report on Friday, July 28th.
In other news, Director Harry Fisch acquired 24,750 shares of Female Health Company (The) stock in a transaction that occurred on Monday, May 22nd. The shares were acquired at an average price of $1.02 per share, for a total transaction of $25,245.00. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Mitchell Shuster Steiner acquired 55,000 shares of Female Health Company (The) stock in a transaction that occurred on Monday, June 12th. The shares were purchased at an average price of $1.27 per share, for a total transaction of $69,850.00. Following the transaction, the insider now directly owns 645,502 shares in the company, valued at $819,787.54. The disclosure for this purchase can be found here. Insiders have purchased a total of 205,569 shares of company stock worth $241,267 in the last 90 days. 10.90% of the stock is currently owned by corporate insiders.
About Female Health Company (The)
The Female Health Company is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.
Receive News & Ratings for Female Health Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Female Health Company (The) and related companies with our FREE daily email newsletter.